"Designing Growth Strategies is in our DNA"

U.S. Veterinary Vaccines Market Size, Share & COVID-19 Impact Analysis, By Product (Inactivated, Live Attenuated, Recombinant, and Others), By Animal (Companion and Livestock), By Route of Administration (Oral, Parenteral, and Others), and By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, and Others), and Country Forecast, 2023-2030

Last Updated: February 24, 2025 | Format: PDF | Report ID: FBI108742

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Major Animal Diseases in U.S., 2022
    2. Livestock and Companion Animal Ownership Patterns in U.S., 2022
    3. Recent Industry Developments such as Mergers & Acquisitions
    4. Overview of Regulatory Scenario – Veterinary Vaccines
    5. Overview of Novel Vaccine Delivery Modes
    6. Impact of COVID-19 on the Market
  5. U.S. Veterinary Vaccines Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product
      1. Inactivated
      2. Live Attenuated
      3. Recombinant
      4. Others
    2. Market Analysis, Insights and Forecast – By Animal
      1. Livestock
      2. Companion
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Veterinary Hospitals
      2. Veterinary Clinics
      3. Pharmacies & Drug Stores
      4. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. Elanco
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. HIPRA
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Boehringer Ingelheim International GmbH
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Virbac
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. MSD Animal Health
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Zoetis
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Ceva
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. NEOGEN CORPORATION
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. Hester Biosciences Limited
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 1: U.S. Veterinary Vaccines Market Revenue Breakdown (USD billion, %), By Product, 2022 & 2030

Figure 2: U.S. Veterinary Vaccines Market Value Share (%), By Product, 2022 & 2030

Figure 3: U.S. Veterinary Vaccines Market Value Share (%), By Animal, 2022 & 2030

Figure 4: U.S. Veterinary Vaccines Market Value Share (%), By Route of Administration, 2022 & 2030

Figure 5: U.S. Veterinary Vaccines Market Value Share (%), By Distribution Channel, 2022 & 2030

Figure 6: U.S. Veterinary Vaccines Market Share (%), 2022

Table 1: U.S. Veterinary Vaccines Market Revenue (USD billion) Forecast, By Product, 2019–2030

Table 2: U.S. Veterinary Vaccines Market Revenue (USD billion) Forecast, By Animal, 2019–2030

Table 3: U.S. Veterinary Vaccines Market Revenue (USD billion) Forecast, By Route of Administration, 2019–2030

Table 4: U.S. Veterinary Vaccines Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2030

U.S. Veterinary Vaccines Market Size, Share and Global Industry Trend Forecast till 2030
  • 2019-2030
  • 2022
  • 2019-2021
  • 80
Consulting Services
    How will you benefit from our consulting services ?